Literature DB >> 35445143

Adjuvant Radiation in Early Stage Vulvar Cancer: A Review of Indications and Optimal Dose.

Karishma Khullar1, Tomas Patrich2, Salma K Jabbour1, Lara Hathout1.   

Abstract

Vulvar cancer is a relatively rare gynecologic malignancy for which surgery remains the cornerstone of treatment. A wide local excision is the goal for treatment with curative intent in patients with early stage vulvar cancer, given that there are adverse pathologic features shown to increase risk of local recurrence. Specifically, the presence of positive or close margins of < 8 mm or 2 or more positive nodes have been shown to significantly increase the risk of recurrence and have informed guidelines for risk-adapted adjuvant radiation, although the optimal dose for adjuvant radiation is yet to be established. Given the rarity of vulvar cancer, guidelines regarding the indications and dose for adjuvant radiation are based largely on retrospective studies. The purpose of this review is to summarize the evidence underlying the current indications for adjuvant radiation in early stage vulvar cancer as well as to determine the optimal dose for adjuvant radiation.

Entities:  

Keywords:  adjuvant radiation; early stage; management; radiation dose; vulvar cancer

Year:  2022        PMID: 35445143      PMCID: PMC9017798     

Source DB:  PubMed          Journal:  Appl Radiat Oncol        ISSN: 2334-5446


  40 in total

1.  Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva.

Authors:  J M Heaps; Y S Fu; F J Montz; N F Hacker; J S Berek
Journal:  Gynecol Oncol       Date:  1990-09       Impact factor: 5.482

2.  Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva.

Authors:  T W Burke; C A Stringer; D M Gershenson; C L Edwards; M Morris; J T Wharton
Journal:  Gynecol Oncol       Date:  1990-09       Impact factor: 5.482

3.  Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions.

Authors:  N F Hacker; R S Leuchter; J S Berek; T W Castaldo; L D Lagasse
Journal:  Obstet Gynecol       Date:  1981-11       Impact factor: 7.661

4.  Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.

Authors:  Charles F Levenback; Shamshad Ali; Robert L Coleman; Michael A Gold; Jeffrey M Fowler; Patricia L Judson; Maria C Bell; Koen De Geest; Nick M Spirtos; Ronald K Potkul; Mario M Leitao; Jamie N Bakkum-Gamez; Emma C Rossi; Samuel S Lentz; James J Burke; Linda Van Le; Cornelia L Trimble
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544

5.  Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial.

Authors:  Charles Kunos; Fiona Simpkins; Heidi Gibbons; Chunqiao Tian; Howard Homesley
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

6.  ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer.

Authors:  Shruti Jolly; Payal Soni; David K Gaffney; Matthew Biagioli; Mohamed A Elshaikh; Anuja Jhingran; Elizabeth Kidd; Larissa J Lee; Linna Li; David H Moore; Gautam G Rao; Andrew O Wahl; Ned L Williams; Catheryn M Yashar; William Small
Journal:  Oncology (Williston Park)       Date:  2015-11       Impact factor: 2.990

7.  Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis.

Authors:  Emilie Serre; Emilie Raimond; Caroline Diguisto; Sofiane Bendifallah; Gilles Body; Cyril Touboul; Olivier Graesslin; Xavier Carcopino; Emile Daraï; Lobna Ouldamer
Journal:  Acta Oncol       Date:  2019-11-12       Impact factor: 4.089

8.  Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins.

Authors:  Tanja Ignatov; Holm Eggemann; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-02       Impact factor: 4.553

Review 9.  Reducing the radicality of surgery for vulvar cancer: are smaller margins safer?

Authors:  Sarah Milliken; James May; Peter A Sanderson; Mario A Congiu; Ottavia D'Oria; Tullio Golia D'Augè; Giuseppe Caruso; Violante DI Donato; Pierluigi Benedetti Panici; Andrea Giannini
Journal:  Minerva Obstet Gynecol       Date:  2020-12-11

10.  Potential delay in the diagnosis of vulvar cancer and associated risk factors in women treated in German gynecological practices.

Authors:  Jennifer Muigai; Louis Jacob; Konstantinos Dinas; Karel Kostev; Matthias Kalder
Journal:  Oncotarget       Date:  2018-01-03
View more
  1 in total

1.  Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups.

Authors:  Gabriella Macchia; Calogero Casà; Martina Ferioli; Valentina Lancellotta; Donato Pezzulla; Brigida Pappalardi; Concetta Laliscia; Edy Ippolito; Jacopo Di Muzio; Alessandra Huscher; Francesca Tortoreto; Mariangela Boccardi; Roberta Lazzari; Pierandrea De Iaco; Francesco Raspagliesi; Angiolo Gadducci; Giorgia Garganese; Gabriella Ferrandina; Alessio Giuseppe Morganti; Luca Tagliaferri
Journal:  Radiol Med       Date:  2022-09-10       Impact factor: 6.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.